Otolaryngology Doctors in American Samoa Medicare Details, Address, Contact
4 Otolaryngology doctors found. Showing 1 - 4
 Mr. Malaela Litai Tuioletai, M.B.B.S. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 96799 Turner Drive, Pago Drive, AS 96799 Phone: 684-633-1222 Fax: 684-633-2893 |
 Ms. Hong Su, MBBS. ENT DIPLOMA Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 96799 Turner Drive, Pago Pago, AS 96799 Phone: 684-633-1222 Fax: 684-633-2893 |
Winifredo Salazar Tiangco, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 11155 Turner Drive, Pago Pago, AS 96799 Phone: 684-633-1222 |
Mr. Larry Lagatiana, M.B.B.S Otolaryngology Medicare: Medicare Enrolled Practice Location: Po Box Lbj, Pago Pago, AS 96799 Phone: 684-633-1222 Fax: 684-633-2893 |
News Archive
Shire announces FDA approval of Vyvanse Capsules CII for ADHD in adolescents
Shire plc, the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) approved the prescription medication Vyvanse® (lisdexamfetamine dimesylate) Capsules CII for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adolescents ages 13 to 17. The approval is based on study data demonstrating that Vyvanse improved ADHD symptoms compared to placebo in adolescents with ADHD. Vyvanse is also indicated for the treatment of ADHD in children ages 6 to 12 years, and adults.
AANS, CNS urge Congress to restore Medicare payments for stereotactic radiosurgery
he American Association of Neurological Surgeons and Congress of Neurological Surgeons are urging Congress to restore Medicare hospital outpatient payment rates for Cobalt-60-based stereotactic radiosurgery to those in place prior to the enactment of the American Taxpayer Relief Act.
Boston Scientific to pay $22M for settlement of Guidant post-market survey investigation
Boston Scientific Corporation today announced that it has entered into a civil settlement with the U.S. Department of Justice regarding the Department's investigation relating to certain post-market surveys conducted by Guidant Corporation before Boston Scientific acquired Guidant in 2006. Boston Scientific had previously disclosed the investigation, which was conducted by the United States Attorney's office in Boston.
Study reveals negative long-term effects of heavy cannabis use on brain function and behavior
Young people with cannabis dependence have altered brain function that may be the source of emotional disturbances and increased psychosis risk that are associated with cannabis abuse, according to a new study published in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging.
› Verified 1 days ago